Severe autoimmune hemolytic anemia complicating hereditary spherocytosis treated successfully with glucocorticoids and cyclosporine: a case report

References

• Jager U, Barcellini W, Broome CM, et al. Diagnosis and treatment of autoimmune hemolytic anemia in adults: recommendations from the first international consensus meeting. Blood Rev. 2020;41:100648. doi:10.1016/j.blre.2019.100648
   PubMed Web of Science ®Google Scholar
• Hill QA, Hill A, Berentsen S. Defining autoimmune hemolytic anemia: a systematic review of the terminology used for diagnosis and treatment. Blood Adv. 2019;3:1897–1906. doi:10.1182/bloodadvances.2019000036
   PubMed Web of Science ®Google Scholar
• Barcellini W. New insights in the pathogenesis of autoimmune hemolytic anemia. Transfus Med Hemother. 2015;42:287–293. doi:10.1159/000439002
   PubMed Web of Science ®Google Scholar
• Bass GF, Tuscano ET, Tuscano JM. Diagnosis and classification of autoimmune hemolytic anemia. Autoimmun Rev. 2014;13:560–564. doi:10.1016/j.autrev.2013.11.010
   PubMed Web of Science ®Google Scholar
• Phillips J, Henderson AC. Hemolytic anemia: evaluation and differential diagnosis. Am Fam Physician. 2018;98:354–361. PMID: 30215915.
   PubMed Web of Science ®Google Scholar
• Perrotta S, Gallagher PG, Mohandas N. Hereditary spherocytosis. Lancet. 2008;372:1411–1426. doi:10.1016/S0140-6736(08)61588-3
   PubMed Web of Science ®Google Scholar
• Wang C, Cui Y, Li Y, et al. A systematic review of hereditary spherocytosis reported in Chinese biomedical journals from 1978 to 2013 and estimation of the prevalence of the disease using a disease model. Intractable Rare Dis Res. 2015;4:76–81. doi:10.5582/irdr.2015.01002
   PubMedGoogle Scholar
• Iolascon A, Andolfo I, Russo R. Advances in understanding the pathogenesis of red cell membrane disorders. Br J Haematol. 2019;187:13–24. doi:10.1111/bjh.16126
   PubMed Web of Science ®Google Scholar
• King MJ, Garcon L, Hoyer JD, et al. ICSH guidelines for the laboratory diagnosis of nonimmune hereditary red cell membrane disorders. Int J Lab Hematol. 2015;37:304–325. doi:10.1111/ijlh.12335
   PubMed Web of Science ®Google Scholar
• He BJ, Liao L, Deng ZF, et al. Molecular genetic mechanisms of hereditary spherocytosis: current perspectives. Acta Haematol. 2018;139:60–66. doi:10.1159/000486229
   PubMed Web of Science ®Google Scholar
• Steinberg-Shemer O, Tamary H. Impact of next-generation sequencing on the diagnosis and treatment of congenital anemias. Mol Diagn Ther. 2020;24:397–407. doi:10.1007/s40291-020-00478-3
   PubMed Web of Science ®Google Scholar
• Zaninoni A, Fermo E, Vercellati C, et al. Congenital hemolytic anemias: Is there a role for the immune system? Front Immunol. 2020;11:1309. doi:10.3389/fimmu.2020.01309
   PubMed Web of Science ®Google Scholar
• Silva R, Amarasinghe D, Perera S, et al. A systematic review on diagnostic methods of red cell membrane disorders in Asia. Int J Lab Hematol. 2022;44:248–262. doi:10.1111/ijlh.13800
   PubMed Web of Science ®Google Scholar
• Boguslawska DM, Heger E, Listowski M, et al. A novel L1340P mutation in the ANK1 gene is associated with hereditary spherocytosis? Br J Haematol. 2014;167:269–271. doi:10.1111/bjh.12960
   PubMed Web of Science ®Google Scholar
• Qin L, Nie Y, Zhang H, et al. Identification of new mutations in patients with hereditary spherocytosis by next-generation sequencing. J Hum Genet. 2020;65:427–434. doi:10.1038/s10038-020-0724-z
   PubMed Web of Science ®Google Scholar
• Meulenbroek EM, Wouters D, Zeerleder SS. Lyse or not to lyse: clinical significance of red blood cell autoantibodies. Blood Rev. 2015;29:369–376. doi:10.1016/j.blre.2015.05.001
   PubMed Web of Science ®Google Scholar
• Ahrens N, Pruss A, Kahne A, et al. Coexistence of autoantibodies and alloantibodies to red blood cells due to blood transfusion. Transfusion. 2007;47:813–816. doi:10.1111/j.1537-2995.2007.01194.x
   PubMed Web of Science ®Google Scholar
• Raos M, Lukic M, Pulanic D, et al. The role of serological and molecular testing in the diagnostics and transfusion treatment of autoimmune haemolytic anaemia. Blood Transfus. 2022;20:319–328. doi:10.2450/2021.0235-21
   PubMed Web of Science ®Google Scholar
• Branch DR, Petz LD. Detecting alloantibodies in patients with autoantibodies. Transfusion. 1999;39:6–10. doi:10.1046/j.1537-2995.1999.39199116888.x
   PubMed Web of Science ®Google Scholar
• Leger RM, Garratty G. Evaluation of methods for detecting alloantibodies underlying warm autoantibodies. Transfusion. 1999;39:11–16. doi:10.1046/j.1537-2995.1999.39199116889.x
   PubMed Web of Science ®Google Scholar
• Shirey RS, Boyd JS, Parwani AV, et al. Prophylactic antigen-matched donor blood for patients with warm autoantibodies: an algorithm for transfusion management. Transfusion. 2002;42:1435–1441. doi:10.1046/j.1537-2995.2002.00234.x
   PubMed Web of Science ®Google Scholar
• Evers D, van der Bom JG, Tijmensen J, et al. Red cell alloimmunisation in patients with different types of infections. Br J Haematol. 2016;175:956–966. doi:10.1111/bjh.14307
   PubMed Web of Science ®Google Scholar
• Fasano RM, Booth GS, Miles M, et al. Red blood cell alloimmunization is influenced by recipient inflammatory state at time of transfusion in patients with sickle cell disease. Br J Haematol. 2015;168:291–300. doi:10.1111/bjh.13123
   PubMed Web of Science ®Google Scholar
• Gerritsma JJ, Oomen I, Meinderts S, et al. Back to base pairs: what is the genetic risk for red bloodcell alloimmunization? Blood Rev. 2021;48:100794. doi:10.1016/j.blre.2020.100794
   PubMed Web of Science ®Google Scholar
• Motta I, Giannotta J, Ferraresi M, et al. Autoimmune hemolytic anemia as a complication of congenital anemias. A Case Series and Review of the Literature. J Clin Med. 2021;10: 3439. doi:10.3390/jcm10153439
   Google Scholar
• Barcellini W, Zaninoni A, Giannotta JA, et al. New insights in autoimmune hemolytic anemia: from pathogenesis to therapy stage 1. J Clin Med. 2020;9:3859. doi:10.3390/jcm9123859
   PubMed Web of Science ®Google Scholar
• Zaninoni A, Vercellati C, Imperiali FG, et al. Detection of red blood cell antibodies in mitogen-stimulated cultures from patients with hereditary spherocytosis. Transfusion. 2015;55:2930–2938. doi:10.1111/trf.13257
   PubMed Web of Science ®Google Scholar
• Johnson ST, Puca KE. Evaluating patients with autoimmune hemolytic anemia in the transfusion service and immunohematology reference laboratory: pretransfusion testing challenges and best transfusion-management strategies. Hematology Am Soc Hematol Educ Program. 2022;2022:96–104. doi:10.1182/hematology.2022000406
   PubMedGoogle Scholar
• Fattizzo B, Cantoni S, Giannotta JA, et al. Efficacy and safety of cyclosporine A treatment in autoimmune cytopenias: the experience of two Italian reference centers. Ther Adv Hematol. 2022;13:204062072210977. doi:10.1177/20406207221097780
   Web of Science ®Google Scholar
• Hill QA, Stamps R, Massey E, et al. Guidelines on the management of drug-induced immune and secondary autoimmune, haemolytic anaemia. Br J Haematol. 2017;177:208–220. doi:10.1111/bjh.14654
   PubMed Web of Science ®Google Scholar
• Baratta L, Golluscio V, Delfino M. Favorable response to cyclosporin A in a patient with steroid resistant autoimmune haemolytic anaemia. Recenti Prog Med. 2004;95:100. PMID:15074296.
   PubMedGoogle Scholar
• Sarper N, Caki Kilic S, Zengin E, et al. Management of autoimmune hemolytic anemia in children and adolescents: A single center experience. Turk J Haematol. 2011;28:198–205. doi:10.5152/tjh.2011.54
   PubMed Web of Science ®Google Scholar
• Lauro A, Stanzani M, Finelli C, et al. Alemtuzumab plus cyclosporine treatment of the autoimmune hemolytic anemia in an adult bowel transplant. Case Rep Transplant. 2014;2014:262953. doi:10.1155/2014/262953
   PubMedGoogle Scholar